Kawasaki Disease

참고문헌 (99)

1. , 1967, 178~222
2. , 1968, 291~7
3. , 1971, 2545~59
4. "prevailing in Japan", pp.271~6 (1974)
5. "Clinical spectrum of Kawasaki disease in infants younger than 6 months of age", pp.759~63 (1986)
6. "Hydrops of the gallbladder associated with Kawasaki syndrome", pp.956~9 (1987)
7. , 1993, 68~72
8. , 2000, 153~60
9. "Decreased CD5+ B cells during the acute phase of Kawasaki disease", 37, pp.52~8 (1996)
10. "Apoptosis of peripheral blood mononuclear cells in Kawasaki disease", 27, pp.801~6 (2000)
11. "Cerebrospinal fluid profile in patients with acute Kawasaki disease", 17, pp.478~81 (1998)
12. "Serum HDL-cholesterol and lipoprotein fraction in Kawasaki disease", pp.1039~44 (1982)
13. "Altered lipid profile after Kawasaki syndrome", pp.625~31 (1991)
14. "Serum amyloid A and high density lipoprotein participate in the acute phase response of Kawasaki disease", 42, pp.651~5 (1997)
15. "Kawasaki disease in infants less than one year of age", 126, pp.524~9 (1995)
16. "Kawasaki disease in the older child", 102 (1998)
17. "Kawasaki disease in older children and adolescents", 137, pp.250~2 (2000)
18. "Incidence survey of Kawasaki disease in 1997 and 1998 in Japan" (2001)
19. "Kawasaki syndrome hospitalizations in the United States, 1997 and 2000", pp.495~501 (2003)
20. "The incidence of Kawasaki disease in the United States did not increase between 1988 and 1997", 111, pp.1124~5 (2003)
21. "Epidemiologic picture of Kawasaki disease in Korea", 47, pp.382~7 (2005)
22. "Results of the nationwide epidemiologic survey of Kawasaki disease in 1995 and 1996 in Japan", 102 (1998)
23. "Kawasaki disease in families", pp.666~9 (1989)
24. "Genetic analysis of Kawasaki syndrome", pp.537~9 (1986)
25. "Epidemiologic pictures of Kawasaki disease in Japan from the nationwide incidence survey in 1991 and 1992", 95, pp.475~9 (1995)
26. "Kawasaki disease in a father and daughter", 88, pp.791~2 (1999)
27. "Images in cardiovascular medicine", 97, pp.410~1 (1998)
28. "Kawasaki disease in parents and children", 92, pp.694~7 (2003)
29. "Selective expansion of T cells expressing T-cell receptor variable regions V beta 2 and V beta 8 in Kawasaki disease", pp.4066~70 (1992)
30. "Evidence for selection of 11 amino acid CDR3 domains in V kappa III-derived immunoglobulin light chains in Kawasaki disease", 26, pp.350~4 (1997)
31. "Evidence for superantigen involvement in cardiovascular injury due to Kawasaki syndrome", 155, pp.5018~21 (1995)
32. "Prevalence of superantigen-secreting bacteria in patients with Kawasaki disease", 140, pp.742~6 (2002)
33. "Clonal expansion of CD8+ T cells in Kawasaki disease", 157, pp.481~6 (1997)
34. "Oligoclonal IgA response in the vascular wall in acute Kawasaki disease", 166, pp.1334~43 (2001)
35. , 2002, 299~314
36. "Immunoglobulin allotypic markers in Kawasaki disease", pp.84~6 (1993)
37. "High incidence of angiotensin I converting enzyme genotype II in Kawasaki disease patients with coronary aneurysm", 156, pp.266~8 (1997)
38. "Tumor necrosis factor-alpha levels and promoter polymorphism in patients with Kawasaki disease in Korea", 44, pp.1021~6 (2003)
39. "Polymorphism of transmembrane region of MICA gene and Kawasaki disease", 17, pp.130~7 (2000)
40. "Methylenetetrahydrofolate reductase polymorphism in Kawasaki disease", 42, pp.236~40 (2000)
41. "Monocyte chemoattractant protein 1 gene regulatory region polymorphism and serum levels of monocyte chemoattractant protein 1 in Japanese patients with Kawasaki disease", 44, pp.2211~12 (2001)
42. "Interleukin 6 gene promoter polymorphism is not associated with Kawasaki disease", 2, pp.357~62 (2001)
43. "Increased frequency of alleles associated with elevated tumor necrosis factor-alpha levels in children with Kawasaki disease", 49, pp.686~90 (2001)
44. "Polymorphism of SLC11A1 gene confers susceptibility to Kawasaki disease", 187, pp.326~9 (2003)
45. "A polymorphism in the promoter of the CD14 gene is associated with the development of coronary artery lesions in patients with Kawasaki disease", 143, pp.357~62 (2003)
46. "Association of mannose- binding lectin genotype with cardiovascular abnormalities in Kawasaki disease", 361, pp.1268~70 (2003)
47. "With particular emphasis on arterial lesions", pp.785~97 (1991)
48. "CD8 T lymphocytes and macrophages infiltrate coronary artery aneurysms in acute Kawasaki disease", 184, pp.940~3 (2001)
49. "Systemic arterial expression of matrix metalloproteinases 2 and 9 in acute Kawasaki disease", 23, pp.576~81 (2003)
50. "Peripheral blood monocyte", macrophages and serum tumor necrosis factor in Kawasaki disease, clinimmunolimmunopathol1988, 247~51
51. "Circulating interleukin-1 beta in patients with Kawasaki disease", pp.1670~1 (1988)
52. "Serum interleukin-6 in Kawasaki disease" (1992)
53. "Raised serum interleukin 15 levels in Kawasaki disease", 62, pp.264~6 (2003)
54. "Circulating interleukin 17 is increased in the acute stage of Kawasaki disease", 32, pp.364~6 (2003)
55. , 2001, 130~7
56. "Serum soluble E-selectin levels in Kawasaki disease", pp.283~6 (1994)
57. "IgA plasma cell infiltration of proximal respiratory tract, pancreas, kidney, and coronary artery in acute Kawasaki disease", 182, pp.1183~91 (2000)
58. "Elevated serum levels of matrix metalloproteinase-9 (MMP-9) in Kawasaki disease", 125, pp.340~4 (2001)
59. "Expression of CD40 ligand on CD4+ T-cells and platelets correlated to the coronary artery lesion and disease progress in Kawasaki disease", 111, pp.140~7 (2003)
60. "Increased serum levels of vascular endothelial growth factor in Kawasaki disease", 44, pp.596~9 (1998)
61. "Evidence for RANTES, monocyte chemotactic protein-1, and macrophage inflammatory protein-1 beta expression in Kawasaki disease", 24, pp.1179~85 (1997)
62. "Serum levels of tumor necrosis factor and interferon-gamma in Kawasaki disease involved coronary-artery lesions", pp.29~36 (1990)
63. "Serial changes of serum interleukin-6 and tumor necrosis factor alpha among patients with Kawasaki disease", pp.924~8 6 (1992), Lin CY Lin CC
64. "Increased serum interleukin-10 level in Kawasaki disease", 37, pp.125~30 (1996)
65. , 1992, 1657~66
66. , 2005, 315~20
67. "The prevention of coronary artery aneurysm in Kawasaki disease: a meta-analysis on the efficacy of aspirin and immunoglobulin treatment", 96, pp.1057~61 (1995)
68. "High-dose intravenous gammaglobulin for Kawasaki disease", shi(miya k), pp.1055~8 (1984)
69. "The treatment of Kawasaki syndrome with intravenous gamma globulin", pp.341~7 (1986)
70. "controlled trial of intravenous gamma globulin therapy in children with acute Kawasaki disease", pp.347~54 (1994), A multicenter
71. "Prevalence of coronary artery abnormalities in Kawasaki disease is highly dependent on gamma globulin dose but independent of salicylate dose", 131, pp.888~93 (1997)
72. "Effects of intravenous immune globulin on the peripheral lymphocyte phenotypes in Kawasaki disease", 37, pp.357~63 (1996)
73. "Modulation of endothelial cell function by normal polyspecific human intravenous immunoglobulins: a possible mechanism of action in vascular diseases", 153, pp.1257~66 (1998)
74. "Coronary risk factors in acute Kawasaki disease: correlation of serum immunoglobulin levels with coronary complications", 40, pp.218~25 (1998)
75. "Factors relating to the cardiac sequelae of Kawasaki disease one month after initial onset", 91, pp.517~20 (2002)
76. "Early intravenous gamma-globulin treatment for Kawasaki disease the nationwide surveys in Japan", 144, pp.496~9 (2004)
77. "Late intravenous gamma globulin treatment in infants and children with Kawasaki disease and coronary artery abnormalities", pp.796~7 (1991)
78. "2003 Report of the Committee on Infectious Diseases" (2003), American Academy of Pediatrics
79. "effect of treatment on coronary artery involvement", pp.175~9 (1979)
80. "Corticosteroids in the treatment of the acute phase of Kawasaki disease", 135, pp.465~9 (1999)
81. "Corticosteroids in the initial treatment of Kawasaki disease: report of a randomized trial", 142, pp.611~6 (2003)
82. "Effect of corticosteroids in addition to intravenous gamma globulin therapy on serum cytokine levels in the acute phase of Kawasaki disease in children", 143, pp.363~7 (2003)
83. "Intravenous gamma-globulin treatment and retreatment in Kawasaki disease", 17, pp.1144~8 (1998)
84. "Initial intravenous gammaglobulin treatment failure in Kawasaki disease", 105 (2000)
85. "Kawasaki disease: who is at risk?", 137, pp.149~52 (2000)
86. "Treatment of immune globulin-resistant Kawasaki disease with pulsed doses of corticosteroids", 128, pp.146~9 (1996)
87. "Plasma exchange in Kawasaki disease", 346, pp.1307~ (1995)
88. "Ulinastatin, an elastase inhibitor, inhibits the increased mRNA expression of prostaglandin H2 synthase-type 2 in Kawasaki disease", 181, pp.1101~9 (2000)
89. "Infliximab as a novel therapy for refractory Kawasaki disease", 31, pp.808~10 (2004)
90. "Longstanding obliterativepanarteritis in Kawasaki disease lack of cyclosporin A effect", 112, pp.986~92 (2003)
91. "Treatment of intravenous immunoglobulin-resistant Kawasaki disease with methotrexate", 34, pp.136~9 (2005)
92. "A case of intravenous immunoglobulin-resistant Kawasaki disease treated with methotrexate", 43, pp.527~32 (2002)
93. "Ticlopidine plus aspirin for coronary thrombosis in Kawasaki disease", 105 (2000)
94. "Does Abciximab enhance regression of coronary aneurysms resulting from Kawasaki disease?", 109 (2002)
95. "Coronary arterial lesions of Kawasaki disease cardiac catheterization findings of 1100 cases", pp.3~9 (1986)
96. "Guidelines for long-term management of patients with Kawasaki disease Report from the Committee on Rheumatic Fever Council on Cardiovascular Disease in the Young", pp.916~22 (1994)
97. "Valvular heart disease in Kawasaki syndrome", pp.366~72 (1990), incidence and natural history
98. "Cross-sectional echocardiographic diagnosis of coronary artery aneurysms in patients with the mucocutaneous lymph node syndrome", pp.133~9 (1979)
99. "specificity and predictive value of two-dimensional echocardiography in detecting coronary artery aneurysms in patients with Kawasaki disease", hashi(k), pp.355 1379~60 85 (1986)

관련 논문AI추천